Bruno Daniele

18.9k total citations · 6 hit papers
202 papers, 8.4k citations indexed

About

Bruno Daniele is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bruno Daniele has authored 202 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Hepatology, 86 papers in Oncology and 52 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bruno Daniele's work include Hepatocellular Carcinoma Treatment and Prognosis (86 papers), Colorectal Cancer Treatments and Studies (28 papers) and Pancreatic and Hepatic Oncology Research (22 papers). Bruno Daniele is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (86 papers), Colorectal Cancer Treatments and Studies (28 papers) and Pancreatic and Hepatic Oncology Research (22 papers). Bruno Daniele collaborates with scholars based in Italy, United States and France. Bruno Daniele's co-authors include Sandro Pignata, Arndt Vogel, Masatoshi Kudo, Francesco Izzo, Paolo Vallone, Francesco Fiore, Andrew X. Zhu, Steven A. Curley, Lee M. Ellis and Paolo Delrio and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

Bruno Daniele

193 papers receiving 8.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial

2019 1.3k citations Richard S. Finn, Baek‐Yeol Ryoo et al. Journal of Clinical Oncology profile →
Radiofrequency Ablation of Unresectable Primary and Metastatic Hepatic Malignancies

1999 856 citations Francesco Izzo, Paolo Vallone et al. profile →
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2018 712 citations Bruno Daniele, Chris Verslype et al. profile →
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib

2014 449 citations Andrew X. Zhu, Masatoshi Kudo et al. profile →
Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines

2021 306 citations Bruno Daniele, Chris Verslype et al. profile →
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

2018 257 citations Bruno Daniele et al. profile →

Peers

Countries citing papers authored by Bruno Daniele

Since Specialization

Citations

This map shows the geographic impact of Bruno Daniele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Daniele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Daniele more than expected).

Fields of papers citing papers by Bruno Daniele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Daniele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Daniele. The network helps show where Bruno Daniele may publish in the future.

Co-authorship network of co-authors of Bruno Daniele

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Daniele. A scholar is included among the top collaborators of Bruno Daniele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Daniele. Bruno Daniele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early Outcomes, Learning Curve and Cost Analysis of Totally Robotic Sleeve Gastrectomy 2025 ·Obesity Surgery ·Antonio Vitiello, Giovanna Berardi, (unknown), Bruno Daniele, Marcello Persico, Vincenzo Pilone	0
2	Expanding Cancer Prevention: Strategies Integrated into Occupational Health Surveillance 2025 ·Cancers ·Giulia Collatuzzo, Alessandro Godono, Giulia Fiorini, (unknown), (unknown), Valentina Biagioli, Felipe Augusto Pinto-Vidal, Monireh Sadat Seyyedsalehi, (unknown), Ángel Honrado, Bruno Daniele, Adonina Tardón, Dana Mateș, Anna Schneider‐Kamp, Eleonóra Fabiánová, Paolo Boffetta	1
3	Pembrolizumab (pembro) in patients (pts) with sorafenib-treated (cohort 1) and treatment (tx)-naive (cohort 2) advanced hepatocellular carcinoma (aHCC) after additional follow-up in the phase 2 KEYNOTE-224 study. 2024 ·Journal of Clinical Oncology ·Richard S. Finn, Masatoshi Kudo, Ivan Borbath, Julien Edeline, Stéphane Cattan, Hans Van Vlierberghe, Chris Verslype, Daniel H. Palmer, Per Stål, Sadahisa Ogasawara, (unknown), Mark Karwal, Stephen L. Chan, Jennifer J. Knox, Bruno Daniele, (unknown), Ken Hatogai, Abby B. Siegel, Ann‐Lii Cheng, Jean‐Luc Van Laethem	2
4	Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers 2024 ·The Oncologist ·Carmen Belli, Luca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, (unknown), Anna Diana, (unknown), Liliana Ascione, (unknown), Nicola Fusco, Massimo Barberis, Bruno Daniele, Elena Guerini‐Rocco, Giuseppe Curigliano	2
5	Comprehensive Diagnostic Work-Up for Uncovering the Causes of Sudden Cardiac Death: The Role of Family Members 2024 ·SHILAP Revista de lepidopterología ·Emanuele Monda, (unknown), Bruno Daniele, Marta Rubino, Giuseppe Palmiero, Federica Verrillo, (unknown), Annapaola Cirillo, Adelaide Fusco, Martina Caiazza, Santo Dellegrottaglie, Diego Colonna, Berardo Sarubbi, (unknown), Maria Giovanna Russo, Giuseppe Limongelli	1
6	Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study 2023 ·European Journal of Cancer ·Nicola Normanno, Antonella De Luca, Riziero Esposito Abate, Alessandro Morabito, Michèle Milella, Fabrizio Tabbò, Giuseppe Curigliano, Cristina Masini, Paolo Marchetti, Giancarlo Pruneri, Valentina Guarneri, Giovanni Luca Frassineti, Gianpiero Fasola, Vincenzo Adamo, Bruno Daniele, Rossana Berardi, Florinda Feroce, Evaristo Maiello, Carmine Pinto	9
7	Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial 2023 ·Liver Cancer ·Philippe Merle, Masatoshi Kudo, Julien Edeline, Mohamed Bouattour, Ann‐Lii Cheng, Stephen L. Chan, (unknown), Marcelo Garrido, Jennifer J. Knox, Bruno Daniele, В. В. Бредер, Ho Yeong Lim, Sadahisa Ogasawara, Stéphane Cattan, Yee Chao, Abby B. Siegel, Iván Martínez‐Forero, Ziwen Wei, (unknown), (unknown)	31
8	Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience 2023 ·International Journal of Molecular Sciences ·Massimiliano Salati, Michele Ghidini, (unknown), Luca Reggiani Bonetti, (unknown), Andrea Spallanzani, Fabio Gelsomino, (unknown), Ornella Garrone, Bruno Daniele, Massimo Dominici, Antonio Facciorusso, Angelica Petrillo	4
9	Anorectal and Genital Mucosal Melanoma: Diagnostic Challenges, Current Knowledge and Therapeutic Opportunities of Rare Melanomas 2022 ·Biomedicines ·Margaret Ottaviano, Emilio Francesco Giunta, Laura Marandino, (unknown), Laura Attademo, Davide Bosso, Cinzia Cardalesi, Antonietta Fabbrocini, Mario Rosanova, Antonia Silvestri, Liliana Montella, Pasquale Tammaro, Ester Marra, Claudia Trojaniello, Maria Grazia Vitale, Ester Simeone, Teresa Troiani, Bruno Daniele, Paolo A. Ascierto	21
10	Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison 2021 ·Advances in Therapy ·Jörg Trojan, Patrick Mollon, Bruno Daniele, Florence Marteau, (unknown), Yuxin Li, Qing Xu, Fabio Piscaglia, Renata Zaucha, Debashis Sarker, Ho Yeong Lim, Marino Venerito	11
11	Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge” (December 4th–5th, 2019, Naples, Italy) 2021 ·Journal of Translational Medicine ·Paolo A. Ascierto, Lisa H. Butterfield, Kirk A. Campbell, Bruno Daniele, Michael Dougan, Leisha A. Emens, Silvia C. Formenti, Filip Jankú, Samir N. Khleif, Tomas Kirchhoff, Alessandro Morabito, Yana G. Najjar, Paul Nathan, Kunle Odunsi, Akash Patnaik, Chrystal M. Paulos, Bradley I. Reinfeld, Heath D. Skinner, John M. Timmerman, Igor Puzanov	2
12	Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trials 2021 ·Liver International ·Francesco Tovoli, Ingrid Garajová, Fabio Gelsomino, Massimo Iavarone, Piera Federico, Massimiliano Salati, (unknown), Francesco Catanzariti, Stefania De Lorenzo, Alessandro Granito, Matteo Renzulli, Bruno Daniele, Fabio Piscaglia	7
13	Health‐related quality‐of‐life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE‐240 2020 ·Cancer ·Baek‐Yeol Ryoo, Philippe Merle, Amit S. Kulkarni, Ann‐Lii Cheng, Mohamed Bouattour, Ho Yeong Lim, В. В. Бредер, Julien Edeline, Yee Chao, Sadahisa Ogasawara, Thomas Yau, Marcelo Garrido, Stephen L. Chan, Bruno Daniele, Josephine M. Norquist, Erluo Chen, Abby B. Siegel, Andrew X. Zhu, Richard S. Finn, Masatoshi Kudo	25
14	Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial breakdown → 2019 ·Journal of Clinical Oncology ·Richard S. Finn, Baek‐Yeol Ryoo, Philippe Merle, Masatoshi Kudo, Mohamed Bouattour, Ho Yeong Lim, В. В. Бредер, Julien Edeline, Yee Chao, Sadahisa Ogasawara, Thomas Yau, Marcelo Garrido, Stephen L. Chan, Jennifer J. Knox, Bruno Daniele, Scot Ebbinghaus, Erluo Chen, Abby B. Siegel, Andrew X. Zhu, Ann‐Lii Cheng, (unknown)	1300
15	Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy) 2018 ·Journal for ImmunoTherapy of Cancer ·Paolo A. Ascierto, James Brugarolas, Luigi Buonaguro, Lisa H. Butterfield, David P. Carbone, Bruno Daniele, Robert L. Ferris, Bernard A. Fox, Jérôme Galon, Cesare Gridelli, Howard L. Kaufman, Christopher A. Klebanoff, Ignacio Melero, Paul Nathan, Chrystal M. Paulos, Marco Ruella, Ryan J. Sullivan, Hassane M. Zarour, Igor Puzanov	9
16	Hepatic Resection and Percutaneous Ethanol Injection as Treatments of Small Hepatocellular Carcinoma 2003 ·Journal of Clinical Gastroenterology ·Bruno Daniele, Ilario de Sio, Francesco Izzo, (unknown), A Andreana, Roberto Mazzanti, (unknown), Paolo Vallone, Francesco Fiore, G.B. Gaeta, Federica Perrone, Sandro Pignata, Ciro Gallo	44
17	Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial 2001 ·Gut ·Bruno Daniele, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	104
18	Treatment of duodenal ulcers: An update 1993 ·European Journal of Gastroenterology & Hepatology ·Fabio Castiglione, Bruno Daniele, Sandro Pignata, (unknown), G. Mazzacca	2
19	Postheparin Plasma Diamine Oxidase in Subjects with Small Bowel Disease 1988 ·Digestion ·Luciano D’Agostino, Bruno Daniele, Sandro Pignata, Luigi Greco, G. Mazzacca	15
20	Postheparin plasma diamine oxidase increases in patients with coeliac disease during gluten free diet. 1987 ·Gut ·Luciano D’Agostino, Bruno Daniele, Sandro Pignata, Maria Vittoria Barone, Carolina Ciacci, R. Sollazzo, G. Mazzacca	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact